PC Covid-19

Published: 23 May 2022| Version 1 | DOI: 10.17632/crh7tnw3m3.1


PERCUTANEOUS CHOLECYSTOSTOMY IN THE MANAGEMENT OF ACUTE CHOLECYSTITIS – COMPARATIVE ANALYSIS OF BEFORE AND AFTER COVID 19 PANDEMIC Percutaneous Cholecystostomy (PC) is a temporary treatment for acute cholecystitis (AC) in patients with high risk for surgery. In this study, we aimed to compare the characteristics of patients who underwent PC during and before the Covid-19 pandemic. The data of patients who were diagnosed acute cholecystitis (AC) and performed PC between 2019 and 2021 were examined by scanning the hospital registry system. During the Covid-19 pandemic period, it was determined that 110 patients underwent PC procedures between 11 March 2020 and 11 March 2021. In the pre-pandemic period, between March 2019 and 2020, 99 patients who underwent PC were added to the study as a control group. The patient’s characteristics of the two groups were compared. Percutaneous cholecystostomy is an effective and safe treatment, which reducing the operating room load during the exacerbation of the Covid-19 pandemic. During the Covid-19 pandemic, the indications for this minimally invasive treatment may be expanded to avoid interventions, including the need for surgery and intensive care.



Cholecystitis, Patient Characteristics, Cholecystostomy, COVID-19